Abstract

33P Real-world data of furmonertinib for patients with advanced non-small cell lung cancer with EGFR exon 20 insertion mutations

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call